Skip to main content
AU Proudly Based in Australia
Research Use Only | Lab Tested | Secure Checkout
HomePeptidesBundlesResearch AreasQualityResourcesContact
Research Grade Quality Independently Tested

Cagrilintide

≥ 99% (HPLC) CAS 1415456-99-3 C₂₃₁H₃₄₆N₆₀O₆₆S Verified Synthesis Batch COA Available

$119.99

Cagrilintide is an experimental synthetic analog peptide which has gained much interest in the field of metabolic and endocrine research. Being a long acting analog of amylin, it is investigated for its effects on various biological pathways associated with the appetite control, energy balance, gastric physiology and metabolism. Cagrilintide is continuously being investigated in various preclinical and clinical studies for the understanding of these physiological processes.

Size / Strength

HPLC Verified
COA Included
Fast Dispatch
Discreet Shipping
100% Quality Guarantee

Every batch of Cagrilintide is independently third-party tested. 30-day money-back guarantee — no questions asked.

≥ 99% Purity Verified
HPLC Tested & Verified
Cold Chain Temperature Controlled
Next Day Fast & Discreet

Cagrilintide – Research Overview

The Cagrilintide 5mg/10mg from Peptides Australia is provided as Research Use Only (RUO) grade product which can be used for scientific and analytical studies and education purposes. Each batch of the product is tested thoroughly and is accompanied by analytical information per batch.

Research Highlights

What is Cagrilintide?

Cagrilintide is a peptide analogue synthesized to reproduce some biological features of the natural hormone called amylin. Amylin is a natural peptide hormone that is co-secreted along with insulin from pancreatic beta cells.

Amylin functions in many different physiological pathways related to nutrition and energy management.

While amylin is the natural form of the hormone, Cagrilintide is its modified variant. The modifications were aimed at improving the molecule’s stability and biological activity in experiments. It is now widely used in research on metabolism, hormones, satiety and digestive system.

In recent times, the interest of science in the molecule of Cagrilintide has grown because of extensive research work conducted on amylin receptor agonism and signalling pathway mechanism. Scientists at laboratories, biotech companies, and academic institutes keep working on the molecular interaction studies of the compound.

In the lab settings, the use of Cagrilintide is mainly directed towards:

  • Study of Amylin Receptors
  • Metabolic Pathways Signalling
  • Mechanism of Appetite Control
  • Gastrointestinal Physiology
  • Endocrine Communication
  • Energy Homeostasis
  • Neuroendocrine Signalling

While there have been more publications from the scientific literature, Cagrilintide still is an investigational compound that is only available for lab use.

Chemical Properties

Cagrilintide is a type of synthetic analogue peptide, synthesized via peptide engineering approach. It is synthesized through peptide synthesis and further purified before lyophilization.

Typical laboratory characteristics include:

Physical Characteristics

The peptide is supplied as a sterile lyophilised powder designed to maximise stability during transport and laboratory storage.

Lyophilization is a process that greatly decreases water levels and makes it possible to conserve the structure of peptides, as well as to handle the substance under laboratory conditions in a controlled manner.

Each batch undergoes individual testing to confirm its identity, purity, and uniformity prior to distribution.

Why Researchers Examine Cagrilintide

This substance has emerged as an important subject of study in the sphere of metabolism and endocrinology research because of the relationship between it and the amylin receptors. Modern scientific literature reviews such biological processes as:

Appetite Regulation

Scientists attempt to understand the influence of activation of amylin receptors on the signaling pathways of appetite control.

Energy Balance

Experimental studies focus on the mechanisms of maintenance of energy balance via the hormonal networks.

Gastrointestinal Physiology

Laboratory experiments concentrate on the interactions of amylin signalling and gastrointestinal physiology.

Endocrine Communication

Scientific research on the coordination of actions of peptide hormones continues.

Regulatory Pathways of Glucose

Modern scientific literature examines the relation of amylin pathways with endocrine glucose regulatory pathways but recognizes that further study will be necessary to comprehend them thoroughly.

Signalling in Central Nervous System

The neuroendocrine research is focused on the interactions between peripheral peptide hormones and particular regions of the central nervous system involved in metabolic regulation.

Combined Research

At the same time, cagrilintide is studied together with other experimental peptides to increase understanding of complementary biological mechanisms in a laboratory environment.

In these research areas, the investigators focus on better understanding of peptide signaling and not development of therapy.

Production & Quality Control

To ensure the high quality of peptides, laboratory peptides should be produced through accurate manufacturing processes based on quality control.

Solid Phase Peptide Synthesis (SPPS)

For the production of cagrilintide, Solid Phase Peptide Synthesis (SPPS) technology is used which is widely recognized as the most popular way to synthesize complex peptides.

Purification

After production, purification helps to get rid of undesirable substances and partial peptides.

Research Use Only (RUO)

The Cagrilintide produced by Peptides Australia is only indicated for Research Use Only (RUO). The indication RUO suggests that it will only be used for scientific studies and investigations. It is not approved in Australia for therapeutic, diagnostic, veterinary, or any other purposes and therefore is not to be used out of the controlled laboratory environment.

Users of RUO materials are required to meet the following criteria:

  • Institutional research policies
  • Laboratory safety regulations
  • Applicable Australian laws
  • Research ethics

RUO materials are different from the registered drugs in terms of their regulatory approval for clinical trials.

Why choose Peptides Australia

Scientific research requires laboratory materials to be reliable.

Peptides Australia is known to provide:

  • Certificates of Analysis per batch
  • Independent laboratory testing
  • Peptides tested with HPLC
  • Batch traceability
  • Australia-wide delivery
  • Lab packing
  • Quality documentation
  • Product verification

Those researchers who are thinking about purchasing the Cagrilintide in Australia should take a close look at the available Certificate of Analysis and independent laboratory testing documentation.

It helps to support laboratories, universities, biotechnological companies, and other research institutions with well-characterized investigational peptides.

Research Use Only

This product is intended solely for laboratory research purposes. Not for human consumption.

Cagrilintide – Storage & Handling

Storage & Laboratory Handling

Correct storage is an important factor that can greatly affect peptide quality.

General laboratory suggestions include:

To store according to laboratory guidelines of the institution.

To protect from high humidity.

To avoid excessive temperature variations.

To protect from direct light.

To store in labeled packaging if possible.

To note storage conditions in laboratory documentation system.

Laboratories have to follow established Good Laboratory Practice (GLP) procedures for research peptides. Transportation conditions should minimize environmental exposure as well.

Cagrilintide – Technical Specifications

Every batch of Cagrilintide is independently analysed before dispatch. The values below describe the current research batch.

Product NameCagrilintide
CAS Number1415456-99-3
Molecular FormulaC₂₃₁H₃₄₆N₆₀O₆₆S
Molecular Weight4571.3 g/mol
Quantity / Strength5mg | 10mg
Purity ≥ 99% (HPLC)
FormLyophilised Powder
AppearanceWhite Lyophilised Powder
Batch NumberPA-0016
Storage Conditions2°C-8°C (Refrigerated)
CategoryWeight Loss
Intended UseResearch Use Only — not for human consumption

Cagrilintide – Certificate of Analysis

Every batch of Cagrilintide is independently tested before dispatch. View the full COA for the current batch below.

Certificate of Analysis (COA)

Batch Number PA-0016

≥ 99% Purity HPLC
Confirmed Identity Mass Spec
Pass Heavy Metals ICP-MS

Analytical Testing

Each batch of product is subjected to multiple analytical tests, including:

  • High Performance Liquid Chromatography (HPLC)
  • Liquid Chromatography-Mass Spectrometry (LC-MS)
  • Identity confirmation
  • Purity verification
  • Lyophilization

The purified peptide is freeze dried to form a stable lyophilized powder form of the product.

Batch Traceability

Each batch is assigned with a unique identifier to facilitate:

  • Manufacturing records
  • Lab documents
  • Quality investigations
  • Batch verification
  • Manufacturing Process Timeline
  • Peptide Design
  • Solid Phase Peptide Synthesis
  • Purification
  • Analytical Testing
  • Lyophilization
  • Quality Review
  • Batch Release
  • Certificate of Analysis Issue
  • Purity Testing & Certificate of Analysis

Good research starts with well-defined laboratory materials.

Each batch of product should be subjected to analytical testing prior to release.

High-Performance Liquid Chromatography (HPLC)

HPLC is widely used for assessment of peptide purity via separation of molecular constituents.

Scientists review HPLC to evaluate:

  • Percentage of main peak
  • Impurities profile
  • Overall purity

LC-MS Analysis

Liquid Chromatography – Mass Spectrometry will be helpful for confirming molecular identity based on analysis of molecular weight.

The combination of HPLC and LC-MS provides complementary information about peptide quality.

Certificate of Analysis (COA)

The Certificate of Analysis in general covers:

  • Product description
  • Batch number
  • Date of production
  • Purity result
  • Analytical methods used
  • Storage
  • Quality control

Review of analytical certificates will help scientists confirm that the products used meet their laboratory standards prior to any experiments.

Research Disclaimer

For Research Use Only — Not for Human Consumption

This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning Cagrilintide includes preclinical research and ongoing or completed clinical investigations, and further research is needed to establish its safety and efficacy for specific uses.

  • Not for human or veterinary use
  • No claims are made regarding safety or efficacy in humans
  • Must be handled with appropriate laboratory safety equipment
  • Purchaser assumes all responsibility for legal, compliant use

References

5 sources
  1. 1
    Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, et al. Once-Weekly Cagrilintide for Weight Management in People with Overweight and Obesity: A Multicentre, Randomised, Double-Blind, Placebo-Controlled and Active-Controlled, Dose-Finding Phase 2 Trial. The Lancet. 2021;398(10317):2160-2172.PubMed: https://pubmed.ncbi.nlm.nih.gov/34798060/
  2. 2
    Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Concomitant Administration of Multiple Doses of Cagrilintide with Semaglutide 2.4 mg for Weight Management: A Randomised, Controlled, Phase 1b Trial. The Lancet. 2021;397(10286):1736-1748.PubMed: https://pubmed.ncbi.nlm.nih.gov/33894838/
  3. 3
    Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry. 2021;64(15):11183-11194.DOI: https://doi.org/10.1021/acs.jmedchem.1c00565
  4. 4
    Garvey WT, Blüher M, Osorto Contreras CK, Davies MJ, Lehmann EW, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2025.PubMed: https://pubmed.ncbi.nlm.nih.gov/40544433/
  5. 5
    Australian Government, Therapeutic Goods Administration (TGA). Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products. Therapeutic Goods Administration. 19 June 2026.TGA: https://www.tga.gov.au/news/media-releases/concerns-regarding-public-health-risks-associated-unapproved-peptide-products

Citations are provided for research reference and open in a new tab. Listing a study does not imply it evaluated this specific product.

Cagrilintide – Frequently Asked Questions

Stay Updated with New Research
and Exclusive Offers

Subscribe to our newsletter for the latest product updates, research insights and exclusive promotions.

We respect your privacy. Unsubscribe anytime.

Why Researchers Choose Us

Research-Grade Quality. Trusted by Researchers Across Australia.

Learn About Our Quality
Discreet Packaging
Fast Australia-Wide Delivery
Expert Support
30-Day Money Back